Allvivo Vascular is focused on developing advanced antimicrobial technologies aimed at reducing infections associated with medical devices and wounds. The company specializes in creating coatings that utilize engineered antimicrobial peptides, specifically ASP-1 and ASP-2, which are designed to target bacterial pathogens while being biocompatible with host cells. These peptides are notable for their ability to disrupt bacterial membranes, effectively eradicating bacteria within biofilms, which are often resistant to traditional antibiotics. This innovative approach not only enhances the specificity and potency of the antimicrobial agents but also minimizes the risk of developing resistance, making them a promising solution for infection control in medical settings.

In addition to their peptide technology, Allvivo Vascular has developed durable antimicrobial formulations suitable for various medical devices and wound treatments, including biodegradable options. These formulations are engineered to withstand rigorous manufacturing processes and are compatible with sterilization methods, ensuring stability and effectiveness over time. The biocompatibility of these formulations fosters a healing environment while preventing the fouling of device surfaces, thereby improving overall device performance and longevity. Allvivo's technologies offer broad-spectrum antimicrobial protection, effective biofilm prevention, and enhanced stability, positioning the company as a leader in innovative solutions for infection management in healthcare.

United States

Allvivo Vascular is a medical device company that develops biomimetic coatings for devices, offering dual function coatings with nonthrombogenic and antibacterial properties.

Allvivo Vascular

Company Details